Catalyst Pharmaceuticals, Inc. (CPRX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
191,755
398,204
214,203
140,833
119,073
Cost of revenue
30,546
51,967
34,393
21,884
17,039
Gross profit
161,209
346,237
179,810
118,949
102,034
Operating expenses
Research development
20,688
93,150
19,789
16,936
16,497
Selling general and administrative
56,742
133,710
57,085
49,628
44,234
Total operating expenses
77,430
259,425
77,972
66,564
60,731
Operating income or loss
83,779
86,812
101,838
52,385
41,303
Total other income/expenses net
745
7,699
2,881
282
587
Income before tax
84,524
94,511
104,719
52,667
41,890
Income tax expense
17,607
23,101
21,640
13,185
-33,093
Income from continuing operations
66,917
71,410
83,079
39,482
74,983
Net income
66,917
71,410
83,079
39,482
74,983
Net income available to common shareholders
66,917
71,410
83,079
39,482
74,983
Basic EPS
0.58
0.67
0.80
0.38
0.72
Diluted EPS
0.55
0.63
0.75
0.37
0.71
Basic average shares
105,749
106,280
103,375
103,379
103,513
Diluted average shares
113,925
113,753
111,376
107,796
106,242
© 2024 Yahoo. All rights reserved.